Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Moon

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|March 14, 2012
Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survivalJ I Moon, C H D Kwon, J W Joh, et al.
Transplantation Proceedings|May 1, 2010
Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?J M Kim, C H D Kwon, J-W Joh, et al.
Transplantation Proceedings|May 1, 2010
Risk factors for portal vein complications after pediatric living donor liver transplantation with left-sided graftsJ I Moon, G O Jung, G-S Choi, et al.
Transplantation Proceedings|May 1, 2010
Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areasJ M Kim, S J Kim, J-W Joh, et al.
Transplantation Proceedings|May 1, 2010
Preemptive therapy in adult liver transplant recipients in CMV-endemic areaJ M Kim, S J Kim, J-W Joh, et al.
Transplantation Proceedings|May 1, 2010
Living donor liver transplantation in Budd-Chiari syndrome: a single-center experienceG S Choi, J B Park, G O Jung, et al.
Transplantation Proceedings|May 1, 2010
Pharmacokinetics of mycophenolic acid in living donor liver transplantationM Shin, J I Moon, J M Kim, et al.
Transplantation Proceedings|May 1, 2010
The effect of cytomegalovirus antigenemia titer on the efficacy of preemptive therapy for the prevention of cytomegalovirus disease after kidney transplantationG O Jung, S-J Kim, G-S Choi, et al.
Transplantation Proceedings|August 16, 2006
Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patientsS Nishida, D M Levi, J I Moon, et al.
Transplantation Proceedings|December 20, 2000
Cyclosporine nephrotoxicity: the mechanisms of cell injury by cyclosporine A in renal proximal tubular cellsS I Kim, H Y Song, J H Hwang, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|March 14, 2012
Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survivalJ I Moon, C H D Kwon, J W Joh, et al.
Transplantation Proceedings|May 1, 2010
Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?J M Kim, C H D Kwon, J-W Joh, et al.
Transplantation Proceedings|May 1, 2010
Risk factors for portal vein complications after pediatric living donor liver transplantation with left-sided graftsJ I Moon, G O Jung, G-S Choi, et al.
Transplantation Proceedings|May 1, 2010
Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areasJ M Kim, S J Kim, J-W Joh, et al.
Transplantation Proceedings|May 1, 2010
Preemptive therapy in adult liver transplant recipients in CMV-endemic areaJ M Kim, S J Kim, J-W Joh, et al.
Transplantation Proceedings|May 1, 2010
Living donor liver transplantation in Budd-Chiari syndrome: a single-center experienceG S Choi, J B Park, G O Jung, et al.
Transplantation Proceedings|May 1, 2010
Pharmacokinetics of mycophenolic acid in living donor liver transplantationM Shin, J I Moon, J M Kim, et al.
Transplantation Proceedings|May 1, 2010
The effect of cytomegalovirus antigenemia titer on the efficacy of preemptive therapy for the prevention of cytomegalovirus disease after kidney transplantationG O Jung, S-J Kim, G-S Choi, et al.
Transplantation Proceedings|August 16, 2006
Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patientsS Nishida, D M Levi, J I Moon, et al.
Transplantation Proceedings|December 20, 2000
Cyclosporine nephrotoxicity: the mechanisms of cell injury by cyclosporine A in renal proximal tubular cellsS I Kim, H Y Song, J H Hwang, et al.
Pageof 6